These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15319231)

  • 1. Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity.
    Eijsbouts AM; van den Hoogen FH; Laan RF; Sweep CG; Hermus AR; van de Putte LB
    Ann Rheum Dis; 2005 Mar; 64(3):433-7. PubMed ID: 15319231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
    J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation.
    Gutiérrez MA; García ME; Rodriguez JA; Mardonez G; Jacobelli S; Rivero S
    J Rheumatol; 1999 Feb; 26(2):277-81. PubMed ID: 9972958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different threshold for prolactin response to hypoglycaemia in patients with rheumatoid arthritis?
    Imrich R; Vigas M; Rovensky J
    Ann Rheum Dis; 2005 Mar; 64(3):515; author reply 515-6. PubMed ID: 15708916
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
    Wolbink GJ; Voskuyl AE; Lems WF; de Groot E; Nurmohamed MT; Tak PP; Dijkmans BA; Aarden L
    Ann Rheum Dis; 2005 May; 64(5):704-7. PubMed ID: 15485995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M; Nurmohamed MT; Wolbink G; Voskuyl AE; de Koning M; van de Stadt R; Twisk JW; Dijkmans BA; Lems WF
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
    Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P
    J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal plasma steroid relations in glucocorticoid-naïve premenopausal rheumatoid arthritis patients during insulin-induced hypoglycemia test compared to matched normal control females.
    Imrich R; Vigas M; Rovensky J; Aldag JC; Masi AT
    Endocr Regul; 2009 Apr; 43(2):65-73. PubMed ID: 19856711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug.
    Hider SL; Owen A; Hartkoorn R; Khoo S; Back D; Silman AJ; Bruce IN
    Ann Rheum Dis; 2006 Oct; 65(10):1390-3. PubMed ID: 16504991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.
    Hetland ML; Lindegaard HM; Hansen A; Pødenphant J; Unkerskov J; Ringsdal VS; Østergaard M; Tarp U
    Ann Rheum Dis; 2008 Jul; 67(7):1023-6. PubMed ID: 18272669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity and methotrexate treatment.
    Hansen IB; Ellingsen T; Hornung N; Poulsen JH; Lottenburger T; Stengaard-Pedersen K
    J Rheumatol; 2006 Sep; 33(9):1754-9. PubMed ID: 16960937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidaemia in rheumatoid arthritis in a tertiary care centre in Eastern India--a non-randomised trial.
    Ghosh UC; Roy A; Sen K; Kundu AK; Saha I; Biswas A
    J Indian Med Assoc; 2009 Jul; 107(7):427-30. PubMed ID: 20112843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.